相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection
Gregory T. Everson et al.
GASTROENTEROLOGY (2014)
Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource
Donald B. Smith et al.
HEPATOLOGY (2014)
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
Eric Lawitz et al.
LANCET (2014)
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Mark S. Sulkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ever closer to a prophylactic vaccine for HCV
Leo Swadling et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Chronic hepatitis C virus (HCV) disease burden and cost in the United States
Homie Razavi et al.
HEPATOLOGY (2013)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
Important Factors in Reliable Determination of Hepatitis C Virus Genotype by Use of the 5′ Untranslated Region
Koji Hara et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1
Eric Lawitz et al.
JOURNAL OF HEPATOLOGY (2013)
Viral hepatitis and the Global Burden of Disease: a need to regroup
G. S. Cooke et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
Eric Lawitz et al.
LANCET INFECTIOUS DISEASES (2013)
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Eric Lawitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Treatment Outcomes of Treatment-Naive Hepatitis C Patients Co-Infected with HIV: A Systematic Review and Meta-Analysis of Observational Cohorts
Anna Davies et al.
PLOS ONE (2013)
Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS
Nathan Ford et al.
CLINICAL INFECTIOUS DISEASES (2012)
Colonial History and Contemporary Transmission Shape the Genetic Diversity of Hepatitis C Virus Genotype 2 in Amsterdam
Peter V. Markov et al.
JOURNAL OF VIROLOGY (2012)
GBD 2010: design, definitions, and metrics
Christopher J. L. Murray et al.
LANCET (2012)
HCV 6a Prevalence in Guangdong Province Had the Origin from Vietnam and Recent Dissemination to Other Regions of China: Phylogeographic Analyses
Yongshui Fu et al.
PLOS ONE (2012)
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Eleanor Barnes et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The global health burden of hepatitis C virus infection
Francesco Negro et al.
LIVER INTERNATIONAL (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin
G. Uddin et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Emergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological Profiles
Joep de Bruijne et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Genetic History of Hepatitis C Virus in East Asia
Oliver G. Pybus et al.
JOURNAL OF VIROLOGY (2009)
The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis
Gkikas Magiorkinis et al.
PLOS MEDICINE (2009)
The changing epidemiology of hepatitis C virus infection in Europe
Juan I. Esteban et al.
JOURNAL OF HEPATOLOGY (2008)
Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006
Francois Roman et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Sequence diversity of hepatitis C virus: Implications for immune control and therapy
Joerg Timm et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Investigating the endemic transmission of the hepatitis C virus
Oliver G. Pybus et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences
Donald G. Murphy et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users
Yoann Morice et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Comparison of hepatitis C virus NS5b and 5′ noncoding gene sequencing methods in a multicenter study
S Laperche et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Medical progress: Hepatitis C virus infection.
GM Lauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The origin and evolution of hepatitis viruses in humans
P Simmonds
JOURNAL OF GENERAL VIROLOGY (2001)
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
C Frank et al.
LANCET (2000)
分享论文
